Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura

Blood

Volumn 91, Issue 8, 1998, Pages 2839-2846

  Furlan, Miha ^a   Robles, Rodolfo ^a   Solenthaler, Max ^a   Lämmle, Bernhard ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PROTEINASE; VINCRISTINE; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD CHEMISTRY; CASE REPORT; CORTICOSTEROID THERAPY; HUMAN; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; RELAPSE; SPLENECTOMY; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0032522952     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.8.2839.2839_2839_2846     Document Type: Article

References (32)

1. Moake JL: Haemolytic-uraemic syndrome: Basic science. Lancet 343:393, 1994
2. Ruggenenti P, Remuzzi G: The pathophysiology and management of thrombotic thrombocytopenic purpura. Eur J Haematol 56:191, 1996
3. Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, Seder RH, Hong SL, Deykin D: Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 307:1432, 1982
4. Mannucci PM, Lombardi R, Lattuada A, Ruggenenti P, Vigano GL, Barbui T, Remuzzi G: Enhanced proteolysis of plasma von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. Blood 74:978, 1989
5. Sporn LA, Marder VJ, Wagner DD: Inducible secretion of large, biologically potent von Willebrand factor multimers. Cell 46:185, 1986
6. Tsai H-M, Nagel RL, Hatcher VB, Sussman II: Multimeric composition of endothelial cell-derived von Willebrand factor. Blood 73:2074, 1989
7. Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Heliums JD: Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest 78:1456, 1986
8. Dent JA, Berkowitz SD, Ware J, Kasper CK, Ruggeri ZM: Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand disease. Proc Natl Acad Sci USA 87:6306, 1990
9. Dent JA, Galbusera M, Ruggeri ZM: Heterogeneity of plasma von Willebrand factor multimers resulting from proteolysis of the constituent subunit. J Clin Invest 88:774, 1991
10. Furlan M, Robles R, Affolter D, Meyer D, Baillod P, Lämmle B: Triplet structure of von Willebrand factor reflects proteolytic degradation of high molecular weight multimers. Proc Natl Acad Sci USA 90:7503, 1993
11. Furlan M, Robles R, Lämmle B: Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood 87:4223, 1996
12. Tsai H-M: Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 87:4235, 1996
13. Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, Lämmle B: Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood 89:3097, 1997
14. Ruggeri ZM, Zimmerman TS: The complex multimeric composition of factor VIII/von Willebrand factor. Blood 57:1140, 1981
15. Byrnes JJ, Moake JL: Thrombotic thrombocytopenic purpura and haemolytic-uraemic syndrome: Evolving concepts of pathogenesis and therapy. Clin Haematol 15:413, 1986
16. Siddiqui FA, Lian EC-Y: Novel platelet-agglutinating protein from a thrombotic thrombocytopenic purpura plasma. Blood 76:1330, 1985
17. Murphy WG, Moore JC, Kelton JG: Calcium-dependent cysteine protease activity in the sera of patients with thrombotic thrombocytopenic purpura. Blood 70:1683, 1987
18. Falanga A, Consonni R, Ruggenenti P, Barbui T: A cathepsin-like cysteine proteinase proaggregating activity in thrombotic thrombocytopenic purpura. Br J Haematol 79:474, 1991
19. Charba D, Moake JL, Harris MA, Hester JP: Abnormalities of von Willebrand factor multimers in drug-associated thrombotic microangiopathies. Am J Hematol 42:268, 1993
20. Rowe JM, Francis CW, Cyran EM, Marder VJ: Thrombotic thrombocytopenic purpura: Recovery after splenectomy associated with persistence of abnormally large von Willebrand factor multimers. Am J Hematol 20:161, 1985
21. Moore JC, Murphy WG, Kelton JG: Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: An explanation for platelet aggregation in thrombotic thrombocytopenic purpura. Br J Haematol 74:457, 1990
22. Aisenberg AC, Wilkes B: Studies on the suppression of immune responses by the periwinkle alkaloids vincristine and vinblastine. J Clin Invest 43:2394, 1964
23. Coller BS: Inhibition of von Willebrand factor-dependent platelet function by increased platelet cyclic AMP and its prevention by cytoskeleton-disrupting agents. Blood 57:846, 1981
24. Matera C, Falzarano C, Vacca C, Falciani M, Rossi F: Effects of some antineoplastic drugs (vincristine, doxorubicin and epirubicin) on human platelet aggregation. J Med 25:2, 1994
25. Shah NT, Karpen CW, Panganamala RV: In vitro effects of vincristine on arachidonic acid metabolism in human platelets and rat arterial tissue. Thromb Res 23:225, 1981
26. Levin M, Grünwald HW: Use of vincristine in refractory thrombotic thrombocytopenic purpura. Acta Haematol 85:37, 1991
27. O'Connor NTJ, O'Shea MJ, Hill LF: Vincristine for thrombotic thrombocytopenic purpura. Lancet 340:490, 1992
28. Bobbio-Pallavicini E, Porta C, Centurioni R, Gugliotta L, Vianelli N, Tacconi F, Billio A, Ascari E: Vincnstine sulfate for the treatment of thrombotic thrombocytopenic purpura refractory to plasmaexchange. Eur J Haematol 52:222, 1994
29. Moake JL, Rudy CK, Troll JH, Schafer AI, Weinstein MJ, Colannino NM, Hong SL: Therapy of chronic relapsing thrombotic thrombocytopenic purpura with prednisone and azathioprine. Am J Hematol 20:73, 1985
30. Caddis TG, Guthrie TH, Drew MJ, Sahud M, Howe RB, Mittelman A: Treatment of plasma refractory thrombotic thrombocytopenic purpura with protein A immunoabsorption. Am J Hematol 55:55, 1997
31. Moake JL, Byrnes JJ, Troll JH, Rudy CK, Hong SL, Weinstein MJ, Colannino NM: Effects of fresh-frozen plasma and its cryosupernatant fraction on von Willebrand factor multimeric forms in chronic relapsing thrombotic thrombocytopenic purpura. Blood 65:1232, 1985
32. Rock G, Shumak KH, Sutton DMC, Buskard NA, Nair RC: Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Br J Haematol 94:383, 1996